Dr. Locker is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2650 Ridge Ave
Div of Hematologyoncology
Evanston, IL 60201Phone+1 888-909-5222Fax+1 847-570-2336
Education & Training
- National Institutes of Health Clinical CenterFellowship, Medical Oncology, 1976 - 1978
- University of ChicagoResidency, Internal Medicine, 1973 - 1975
- Harvard Medical SchoolClass of 1973
Certifications & Licensure
- IL State Medical License 1974 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Olaparib in gBRCA Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based Chemotherapy Start of enrollment: 2014 Dec 16
Publications & Presentations
PubMed
- 47 citationsThe spectrum of vascular lesions in the mammary skin, including angiosarcoma, after breast conservation treatment for breast cancer.Stephen F. Sener, Steven Milos, Joseph L. Feldman, Carole H Martz, David J. Winchester
Journal of the American College of Surgeons. 2001-07-01 - 1285 citationsMaintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic CancerTalia Golan, Pascal Hammel, Michele Reni, Eric Van Cutsem, Teresa Macarulla
The New England Journal of Medicine. 2019-06-02 - 67 citationsOverall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer.Hedy L Kindler, Pascal Hammel, Michele Reni, Eric Van Cutsem, Teresa Macarulla
Journal of Clinical Oncology. 2022-12-01
Grant Support
- Community Clinical Oncology ProgramNational Cancer Institute2004–2005
- Community Clinical Oncology ProgramNational Cancer Institute2002–2003
- Community Clinical Oncology ProgramNational Cancer Institute1999–2001
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: